MTOR and Alzheimer disease: Within this frame, the rescue of mTOR signalling by the administration of rapamycin, which has been previously tested in AD mouse models demonstrating favorable outcomes [19, 27, 29–31, 78–81], represents a potentially valuable therapeutic strategy.